Citations (9)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Mengxuan Liu, Megumi Honjo, Reiko Yamagishi & Makoto Aihara. (2023) Effects of Brimonidine, Omidenepag Isopropyl, and Ripasudil Ophthalmic Solutions to Protect against H2O2-Induced Oxidative Stress in Human Trabecular Meshwork Cells. Current Eye Research 48:11, pages 1014-1025.
Read now
Read now
Keiji Yoshikawa, Shiro Mizoue, Koji Nitta, Hiroshi Onishi, Masaharu Ikeda, Akemi Mizuno, Kaori Kawazoe, Yoshiyuki Tamada, Ryuji Takeda & Shun Matsumoto. (2021) Stratification-Based Investigation of Adjunctive Brimonidine or Timolol to a Prostaglandin Analogue in Japanese Patients with Normal-Tension Glaucoma. Clinical Ophthalmology 15, pages 2875-2883.
Read now
Read now
Jed Asher Lusthaus & Ivan Goldberg. (2017) Brimonidine and brinzolamide for treating glaucoma and ocular hypertension; a safety evaluation. Expert Opinion on Drug Safety 16:9, pages 1071-1078.
Read now
Read now
Articles from other publishers (6)
Samar A. Salim, Noha M. Badawi, Shahira H. EL-Moslamy, Elbadawy A. Kamoun & Baher A. Daihom. (2023) Novel long-acting brimonidine tartrate loaded-PCL/PVP nanofibers for versatile biomedical applications: fabrication, characterization and antimicrobial evaluation. RSC Advances 13:22, pages 14943-14957.
Crossref
Crossref
Renfeng Xu, Daniel Gil, Mohammed Dibas, Martin Rickert, Dawn Meyer, Laura Perron, Pete Kollbaum & Arthur Bradley. (2020) Time‐course of the visual Impact on presbyopes of a low dose miotic. Ophthalmic and Physiological Optics 41:1, pages 73-83.
Crossref
Crossref
N Cimolai. (2020) A review of neuropsychiatric adverse events from topical ophthalmic brimonidine. Human & Experimental Toxicology 39:10, pages 1279-1290.
Crossref
Crossref
O. N. Onufriichuk, I. R. Gazizova, A. V. Kuroyedov & A. V. Seleznev. (2020) The effect of the main active substances of antihypertensive eye drops on condition of the eyes of glaucoma patients. Pacific Medical Journal:3, pages 5-10.
Crossref
Crossref
Yuko Maruyama, Yoko Ikeda, Norihiko Yokoi, Kazuhiko Mori, Hiroaki Kato, Morio Ueno, Shigeru Kinoshita & Chie Sotozono. (2017) Severe Corneal Disorders Developed After Brimonidine Tartrate Ophthalmic Solution Use. Cornea 36:12, pages 1567-1569.
Crossref
Crossref
Shiro Mizoue, Koji Nitta, Motohiro Shirakashi, Akiyoshi Nitta, Shigeki Yamabayashi, Tairo Kimura, Toshihiko Ueda, Ryuji Takeda, Shun Matsumoto & Keiji Yoshikawa. (2017) Multicenter, Randomized, Investigator-Masked Study Comparing Brimonidine Tartrate 0.1% and Timolol Maleate 0.5% as Adjunctive Therapies to Prostaglandin Analogues in Normal-Tension Glaucoma. Advances in Therapy 34:6, pages 1438-1448.
Crossref
Crossref